Deborah B Nelson1,2, Alexandra L Hanlon3, Guojiao Wu4, Congzhou Liu5,6, David N Fredricks7,8. 1. Department of Obstetrics and Gynecology, Temple University, Philadelphia, PA, USA. dnelson@temple.edu. 2. Department of Public Health, College of Health Professions and Social Work, Temple University, 1301 Cecil B Moore Avenue, Ritter Annex, Room 905, Philadelphia, PA, 19122, USA. dnelson@temple.edu. 3. University of Pennsylvania School of Nursing, Room 479 Fagin Hall, 418 Curie Boulevard, Philadelphia, PA, 19104, USA. alhanlon@nursing.upenn.edu. 4. Department of Statistics, Temple University, Philadelphia, PA, USA. tue70146@temple.edu. 5. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. congzhou@fhcrc.org. 6. Division of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Eastlake Ave, E4-100, Box 358080, Seattle, WA, 98109, USA. congzhou@fhcrc.org. 7. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. dfredric@fhcrc.org. 8. Division of Allergy and Infectious Diseases, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Eastlake Ave, E4-100, Box 358080, Seattle, WA, 98109, USA. dfredric@fhcrc.org.
Abstract
OBJECTIVES: Prior studies have examined the role of bacterial vaginosis (BV) and increased risk of miscarriage; however the risk has been modest and many BV positive pregnant women deliver at term. BV is microbiologically heterogeneous, and thus the identification of specific BV-associated bacteria associated with miscarriage is warranted. METHODS: We measured the presence and level of seven BV-associated bacteria prior to 14 weeks gestation among urban pregnant women seeking routine prenatal care at five urban obstetric practices at Temple University Hospital in Philadelphia PA from July 2008 through September 2011. 418 Pregnant women were included in this assessment and 74 experienced a miscarriage. RESULTS: Mean log concentration of BVAB3 was significantly higher among women experiencing a miscarriage (4.27 vs. 3.71, p value = 0.012). Younger women with high levels of BVAB3 had the greatest risk of miscarriage. In addition, we found a significant decreased risk of miscarriage among women with higher log concentrations of Leptotrichia/Sneathia species or Megasphaera phylotype 1-like species early in pregnancy. CONCLUSIONS FOR PRACTICE: The identification of selected vaginal bacteria associated with an increased risk of miscarriage could support screening programs early in pregnancy and promote early therapies to reduce early pregnancy loss.
OBJECTIVES: Prior studies have examined the role of bacterial vaginosis (BV) and increased risk of miscarriage; however the risk has been modest and many BV positive pregnant women deliver at term. BV is microbiologically heterogeneous, and thus the identification of specific BV-associated bacteria associated with miscarriage is warranted. METHODS: We measured the presence and level of seven BV-associated bacteria prior to 14 weeks gestation among urban pregnant women seeking routine prenatal care at five urban obstetric practices at Temple University Hospital in Philadelphia PA from July 2008 through September 2011. 418 Pregnant women were included in this assessment and 74 experienced a miscarriage. RESULTS: Mean log concentration of BVAB3 was significantly higher among women experiencing a miscarriage (4.27 vs. 3.71, p value = 0.012). Younger women with high levels of BVAB3 had the greatest risk of miscarriage. In addition, we found a significant decreased risk of miscarriage among women with higher log concentrations of Leptotrichia/Sneathia species or Megasphaera phylotype 1-like species early in pregnancy. CONCLUSIONS FOR PRACTICE: The identification of selected vaginal bacteria associated with an increased risk of miscarriage could support screening programs early in pregnancy and promote early therapies to reduce early pregnancy loss.
Authors: Charles P Cartwright; Bryndon D Lembke; Kalpana Ramachandran; Barbara A Body; Melinda B Nye; Charles A Rivers; Jane R Schwebke Journal: J Clin Microbiol Date: 2012-04-25 Impact factor: 5.948
Authors: L Chatenoud; F Parazzini; E di Cintio; G Zanconato; G Benzi; R Bortolus; C La Vecchia Journal: Ann Epidemiol Date: 1998-11 Impact factor: 3.797
Authors: F Parazzini; L Chatenoud; E Di Cintio; R Mezzopane; M Surace; G Zanconato; L Fedele; G Benzi Journal: Hum Reprod Date: 1998-08 Impact factor: 6.918
Authors: Jennifer E Balkus; Sujatha Srinivasan; Omu Anzala; Joshua Kimani; Chloe Andac; Jane Schwebke; David N Fredricks; R Scott McClelland Journal: J Infect Dis Date: 2017-03-01 Impact factor: 5.226
Authors: Kristen R Moore; Meena Tomar; David M Umbach; Scott E Gygax; David W Hilbert; Donna D Baird Journal: Sex Transm Dis Date: 2021-11-01 Impact factor: 3.868
Authors: Marijn C Verwijs; Stephen Agaba; Marie Michele Umulisa; Mireille Uwineza; Adrien Nivoliez; Elke Lievens; Janneke H H M van de Wijgert Journal: BMJ Open Date: 2020-05-19 Impact factor: 2.692
Authors: Michelle C Sabo; Jennifer E Balkus; Barbra A Richardson; Sujatha Srinivasan; Joshua Kimani; Omu Anzala; Jane Schwebke; Tina L Feidler; David N Fredricks; R Scott McClelland Journal: PLoS One Date: 2019-01-24 Impact factor: 3.240
Authors: Antonio Barrientos-Durán; Ana Fuentes-López; Adolfo de Salazar; Julio Plaza-Díaz; Federico García Journal: Nutrients Date: 2020-02-06 Impact factor: 5.717
Authors: Thuy Hoang; Emily Toler; Kevin DeLong; Nomfuneko A Mafunda; Seth M Bloom; Hannah C Zierden; Thomas R Moench; Jenell S Coleman; Justin Hanes; Douglas S Kwon; Samuel K Lai; Richard A Cone; Laura M Ensign Journal: PLoS Pathog Date: 2020-01-23 Impact factor: 6.823